Global Immunosuppressants Market Outlook, Opportunities And Strategies
Learn about the global immunosuppressants market through The Business Research Company, which provides information on immunosuppressants market size, immunosuppressants market drivers and restraints, immunosuppressants market players, the COVID-19 impact on the immunosuppressants market, and more.
Our annual holiday sale is here! Get your discounted market research reports today.
The global immunosuppressants market is expected to grow from $15.04 billion in 2020 to $16.5 billion in 2021 at a compound annual growth rate (CAGR) of 9.7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The immunosuppressant market is expected to reach $25.33 billion in 2025 at a CAGR of 11%.
The surge in organ transplant procedures such as kidney transplant and liver transplant due to the rise in incidences of organ failure is expected to drive innovation in immunosuppressants manufacturing, thus driving the market during the forecast period.
Request A Sample For The Global Immunosuppressants Market Report:
The immunosuppressant market consists of sales of immunosuppressants or anti-rejection drugs generated by companies manufacturing immunosuppressant drugs. Immunosuppressants are medicinal substances that prevent or inhibit activity in the immune system. Immunosuppressive drugs are mainly used in organ transplantation procedures and also in the treatment of certain autoimmune diseases such as rheumatoid arthritis, psoriasis, multiple sclerosis, and others.
Global immunosuppressants market segments include:
By Drug Class: Corticosteroids, Monoclonal Antibodies (MAbs), Calcineurin Inhibitors, mTOR Inhibitors, Anti-Proliferative Agents, Others
By Indication: Organ Transplantation, Autoimmune Disorders, Non-Autoimmune Inflammatory Diseases
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
The phenotypic personalized medicine or PPM or a hybrid of artificial intelligence and physician intervention is a new approach to overcome the issues with immunosuppressants.
TBRC’s immunosuppressants market report covers:
Major Market Players: Astellas Pharma, GlaxoSmithKline, Bristol Myers Squibb, Johnson & Johnson, Intas Pharmaceuticals Ltd., Mylan Laboratories Inc, Pfizer, Novartis, Novartis AG, and Sanofi S.A.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
The Immunosuppressants Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides immunosuppressants market overviews, analyzes and forecasts market size, share, immunosuppressants market players, immunosuppressants market segments and geographies, leading competitor revenues, profiles and market shares.
TBRC’s immunosuppressants market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Here is a list of similar reports from The Business Research Company:
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Blog: https://blog.tbrc.info/
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model